(lp0
S'Stocks: The Wells Fargo &amp; Company MN Has $548000 Position in Corcept ... Petro Global News 24 - Jan 19, 2017 Several other hedge funds have also recently added to or reduced their stakes in CORT. Ingalls &amp; Snyder LLC bought a new position in shares of Corcept Therapeutics during the second quarter valued at approximately $50,059,000. Vanguard Group Inc.'
p1
aS'10.6588 MarketWatch - Dec 21, 2009 Corcept Therapeutics Inc. Corcept Therapeutics, Inc. engages in the development of drugs for the treatment of severe psychiatric, neurological, and metabolic disorders.'
p2
aS'Hot Stocks Among Investors: Corcept Therapeutics Incorporated , Westport ... Post Analyst - 2 hours ago Corcept Therapeutics Incorporated  has made its way to a 12-month gain of 126.53%. Turning to Westport Fuel Systems Inc. , its shares were trading at $1.27 a gain of $0.21, on the trading floor.'
p3
aS"Corcept Therapeutics Rose 18% in March. Here's Why. Motley Fool - Apr 6, 2016 What: Shares of Corcept Therapeutics , small-cap biopharma focused on developing products for the metabolic, psychiatric, and oncologic markets, gained more than 18% in March, according to data from S&amp;P Global Market Intelligence."
p4
aS"Corcept Therapeutics Announces Preliminary Fourth Quarter and Full-Year 2016 ... Marketwired  - Jan 30, 2017 Corcept Therapeutics Incorporated , a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol,&nbsp;...Corcept Therapeutics'  CEO Joseph Belanoff on Q4 2016 Results - Earnings ... - Seeking Alpha"
p5
aS'Street Session Update on Corcept Therapeutics Incorporated  Rockville Register - 21 hours ago During the past trading session, shares of Corcept Therapeutics Incorporated  traded +1.34%. Covering analysts are predicting the stock to move to $11.00 within the next year.The Corcept Therapeutics Incorporated  Position Maintained by Birchview ... - Petro Global News 24Natera  Reaches $7.76 After 4.00% Up Move; Corcept Therapeutics (CORT ... - High Point Observer'
p6
aS'Analyst Views And Outlook On Two Stocks: Corcept Therapeutics Incorporated ... Post Analyst - 16 hours ago Corcept Therapeutics Incorporated  has made its way to a 12-month gain of 118.07%. Turning to Altra Industrial Motion Corp.'
p7
aS"Corcept Therapeutics: Cushing's Syndrome Is Just The Beginning Seeking Alpha - Oct 11, 2016 Shares are up over 40% since the beginning of the year, but there's plenty of upside left based on growth in the company's core business."
p8
aS'Corcept Therapeutics Incorporated  Soars 5.07% on March 28 Equities.com - Mar 28, 2017 Corcept Therapeutics Incorporated  had a good day on the market for Tuesday March 28 as shares jumped 5.07% to close at $11.19.'
p9
aS'Corcept: A Profitable Biotech With A Bright Future Seeking Alpha - Jan 27, 2017 Corcept Therapeutics  is my favorite type of biotech company. It has an approved, marketed product with ramping sales, promising pipeline candidates, and is beginning to turn a profit.'
p10
a.